Why is Malnutrition Important to Monitor in Patients with Cancer?

Video

Nutrition is a vital aspect for patients with cancer, and malnutrition is a concern that must be tracked through the cancer journey.

With certain types of cancer, particularly gastrointestinal (GI) and pancreatic cancers, malnutrition is often a concern, as it leads to weight loss, muscle loss and other damaging side effects. But fortunately, as Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, explains, nutrition is also one of the areas of their health care that a patient can take control of.

In a recent interview with CURE®, Williams explained why it’s important for patients with cancer to stay on top of possible malnutrition, and how that can help improve outcomes in the long run.

Transcription:

Why malnutrition is important, I think, is, there are two aspects. One is the unfortunate nature that, particularly GI cancers, like pancreatic cancer, they cause this cancer cachexia, which is really alterations in food intake and appetite, but also a kind of a pro-inflammatory response related to the cancer, which often leads to weight loss, muscle loss and these changes in overall metabolism. And part of it is does correlate with the aggressiveness of disease. So when we see patients with a lot of symptoms or concerns around weight loss, and cachexia, particularly around these more aggressive inflammatory cancers, like pancreatic cancer, we know that, that usually doesn't go well, meaning these patients are at higher risk for bad outcomes.

But I would say that's one aspect of it. I think the other aspect of it, as both as a provider and a patient, we always want to focus on, what can I do to improve my outcomes? Sure, they've got this cancer, but they want to do something to kind of help. And I would say, we get more questions about nutrition than perhaps almost any question when we're sitting and discussing with patients.

And I think nutrition is one of those areas that patients are starved for information, and it's also just a domain or a facet of health that really they can control to some degree, you know, outside of the cancer itself aspects. So, I think that my interest in it, you know, it's great to assess things that you can't change. But there are some things you can (change), and I would say nutrition is definitely a top aspect for intervention.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Related Content